[en] We determined the tissue and subcellular distributions of Mn(II) by ESR and of total Mn by neutron activation analysis combined with chemical separation. Mn(II) contents of the thyroid, hypophysis, adrenal, pancreas, liver and kidney, tissues were low. In animals treated with Mn(II)Cl, the total Mn content of all tissues increased, but the Mn(II) content remained low. In subcellular distribution, the total Mn content was high in nuclear and mitochondrial fractions of liver and kidney, and in the microsomal and supernatant fractions of the pancreas. The ratio of Mn(II) to total Mn was relatively high in microsomes of the liver and kidney of control rats, and in the nuclear fraction of pancreas of Mn-treated rats. Partially purified liver and mitochondria were found to contain high level of Mn than the crude compartments, indicating that Mn is tightly bound in each cellular compartment. Distribution of Mn in organs and subcellular fractions of rats was investigated. Treatment of STZ resulted in unchanged Mn levels in most organs. Mn content, however, was decreased in the liver mitochondrial fraction and increased in supernatant fraction. Mn levels in both the liver and kidney of rats treated with cisplatin were increased after 7 days of drug administration. The distribution of vanadyl(+4) species estimated by ESR, and total V, determined by neutron activation analysis, were examined in organs and subcellular fractions of the liver of rats treated with vanadyl sulfate or sodium vanadate(+5). Both V compounds distributed in a similar manner in the following order; kidney>serum>liver≅blood>pancreas>testis>lung≅spleen. The ratio of vanadyl ion to total V in a whole homogenate was almost the same after the both treatments, but the ratios in subcellular fractions varies depending on the V compound and the fraction. Approximately 30-70% of the vanadium was reduced to vanadyl form in the subcellular fractions of the liver. (J.P.N.)